AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00878956 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sodium Bicarbonate
Description: In all patients body weight adjusted dose of study medication will be achieved by infusion of sodium bicarbonate at a dose of 0.5 mmol/kg body weight (=bolus) diluted in 250 mL over 1 hour immediately after the induction of anesthesia, prior to the first surgical incision followed by continuous intravenous infusion of 0.2 mmol/kg/hr (=maintenance) diluted in 1000 mL 23 hours (total dose of 5 mmol/kg over 24 hours).
Study NCT00878956 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Sodium Chloride
Description: In all patients body weight adjusted dose of study medication will be achieved by infusion of sodium chloride at a dose of 0.5 mmol/kg body weight (=bolus) diluted in 250 mL over 1 hour immediately after the induction of anesthesia, prior to the first surgical incision followed by continuous intravenous infusion of 0.2 mmol/kg/hr (=maintenance) diluted in 1000 mL 23 hours (total dose of 5 mmol/kg over 24 hours).
Study NCT01865760 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Oral Glucose tolerance test (OGGT)
Description: At baseline subjects will consume 50 g glucose dissolved in water in 10 minutes
Study NCT01865760 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Oral Glucose tolerance test (OGGT)
Description: At baseline subjects will consume 50 g glucose dissolved in water in 10 minutes
Study NCT01865760 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Oral Glucose tolerance test (OGGT)
Description: At baseline subjects will consume 50 g glucose dissolved in water in 10 minutes
Study NCT01865760 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Liquid mixed meal
Description: At baseline subject will consume the liquid mixed meal in 10 minutes
Study NCT01865760 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Liquid mixed meal
Description: At baseline subject will consume the liquid mixed meal in 10 minutes
Study NCT01865760 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Liquid mixed meal
Description: At baseline subject will consume the liquid mixed meal in 10 minutes
Study NCT01865760 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Octreotide
Description: At baseline subjects will receive Octreotid 100 µg subcutaneous
Study NCT02339753 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Blood sampling will be done at the time before administration (0hr pre-dose), 1hr, 2hr, 5hr for pharmacokinetic study.
Study NCT00571155 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: levetiracetam
Description: oral and intravenous dosing 2000-3000 mg per day
Study NCT04365621 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: we enrolled ultra-high risk of psychosis (UHR) patient to describe
Description: there is no intervention because we study only the prevalence of patients meeting UHR criteria
Study NCT02147743 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CCP+MDFT
Description: Multidimensional Family Therapy (MDFT; Liddle, 2002) is one of a new generation of multi-systems oriented family-based intervention for adolescent substance abuse and delinquency. It has demonstrated considerable success with juvenile justice youth at various stages of their involvement in the justice system. The model has demonstrated efficacy in reducing substance use and delinquency, increasing the prosocial behaviors (e.g., family functioning, school outcomes) of substance abusing and court involved adolescents.
Study NCT02147743 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: CCP+SAU
Description: Services As Usual community partners will provide individualized mental health counseling and psychiatric services, psychoeducational groups and substance abuse counseling.
Study NCT03244917 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TRAIN-AD
Description: The study intervention is a multi-component training and education program targeting direct care providers and healthcare proxies for advanced dementia NH residents, intended to improve the management of urinary and lower respiratory tract infections in advanced dementia patients. There are two components to this practice intervention: 1. Provider Training, and 2. Proxy Education. Intervention components aimed at the provider include: Professionally led infection management training seminars, online infection management course, and infection management guidance algorithms. Additionally participating prescribing providers will be sent bimonthly infection management feedback reports. Proxy Education is completed by providing an infection management in Advanced Dementia booklet to proxies of patients with AD upon resident enrollment in study.
Study NCT05888675 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Weifuchun
Description: The treatment group#Weifuchun group#was given Weifuchun tablets, 4 tablets each time, 3 times a day, and 1 hour after meals. The control group(chemotherapy group)#Chemotherapy regimen was based on the Chinese Clinical Oncology Association Guidelines for the Diagnosis and Treatment of Gastric Cancer (2018), including oxaliplatin +5-FU/CF, SOX regimen, XELOX regimen, and Ticeo monotherapy regimen.
Study NCT01064934 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Lipid apheresis
Description: Weekly lipid apheresis procedure for lipoprotein(a) lowering
Study NCT01064934 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard care
Description: Standard care for maximum cardiovascular risk reduction (behavioural, exercise, nutrition, drugs, etc.)
Study NCT04640649 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Algorithm prediction
Description: Patients with early and intermediate AMD in at least one eye who are at risk of converting to wet AMD or GA expansion will be randomly assigned to a test group or control group. The test group will have their baseline data analyzed by an algorithm to predict the probability of conversion to wet AMD. If the probability is high for conversion at or before 3 months, patients will have earlier follow-up care than the control group (standard follow-up care every 6 months).
Study NCT04203095 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: the level of plasma cfDNA CINs
Description: The extracted cfDNA from PB will be analyzed by UCAD to determine the level of CINs.
Study NCT03554629 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Capnography CO2 cannula sampling Flexiterline (CCSF) designs with supplemental O2
Description: Use of 8 post-market nasal CO2 cannula sampling filterlines; 4 nasal only sampling ports manufactured by Medtronic, Salter, Hudson/Teleflex and FlexiCare) and 4 post-market oral/nasal sampling ports manufactured by Medtronic, Salter, Dispo-Med and Westmed during scripted activity with supplemental O2.
Study NCT02665767 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Smartphone-based Telesonography
Description: The 30 participating examiners were randomly divided into two groups. In phase one, group A performed ultrasonography under onsite mentoring and group B performed the same procedure under remote mentoring. Each examiner was randomly assigned one expert and three SPs for phase one. Four weeks later, they were partnered with the same expert and SPs to whom they had been assigned in phase one and performed the procedure under the other type of mentoring (phase two). The examination order of the SPs was randomly assigned by choosing a number between one and six (1: A-B-C, 2: A-C-B, 3: B-A-C, 4: B-C-A, 5: C-A-B, 6: C-B-A) in each phase.
Study NCT03621631 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Optimized Tai Chi intervention
Description: Optimized Tai Chi intervention
Study NCT03621631 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Tai Chi intervention
Description: Traditional Tai Chi intervention
Study NCT02314780 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Heme arginate 3mg/kg
Study NCT02314780 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Heme arginate 1mg/kg
Study NCT02314780 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT02500810 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: monosialoganglioside
Description: 40mg in the vein on day 1 - day 8 of each 21 days cycle. Number of Cycles: 2 cycles.
Study NCT04659577 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ICBT for panic and depression
Description: The most known type of CBT for treating PD consists of two major strategies: cognitive restructuring, and interoceptive and structured exposure to bodily sensations that have become associated with panic attacks. As for depression, the most known type of CBT for treating depression consists of two major strategies: cognitive restructuring, the relationship between thoughts and feelings, behavioural activation, sleep hygiene and relaxation. Each ICBT program includes six modules, containing psychoeducation, cognitive restructuring exposures, acceptance, and consolidation of gains and relapse prevention. The online modules include reading passages, worksheets, videos, and homework assignments. After completing each module participants practice related skills and complete homework assignments. The treatment is up to 16 weeks long; participants are encouraged to complete the treatment within this time period, and reminders are sent to monitor their progress
Study NCT02083107 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Misoprostol
Description: Comparison of different routes of administration of 400 micro gram misoprostol
Study NCT02083107 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT00898209 — intervention group
Intervention type: GENETIC
Intervention: protein expression analysis
Description: Blood and exhaled breath condensate will be collected.
Study NCT00898209 — intervention group
Intervention type: GENETIC
Intervention: proteomic profiling
Description: Blood and exhaled breath condensate will be collected.
Study NCT00898209 — intervention group
Intervention type: OTHER
Intervention: biologic sample preservation procedure
Description: Blood and exhaled breath condensate will be collected.
Study NCT00898209 — intervention group
Intervention type: OTHER
Intervention: laboratory biomarker analysis
Description: Blood and exhaled breath condensate will be collected.
Study NCT00898209 — intervention group
Intervention type: OTHER
Intervention: matrix-asst laser desorption/ionization time flight mass spectrometry
Description: Blood and exhaled breath condensate will be collected.
Study NCT00898209 — intervention group
Intervention type: OTHER
Intervention: questionnaire administration
Description: Questionnaire will be completed.
Study NCT04067934 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Jumping Exercise programme
Description: Four weeks of three jumping-based exercise sessions per week. These sessions will involve basic jumping movements, with approximately 50-100 jumps per session; incorporating 20-30 minutes of exercise.
Study NCT03433963 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: L-Arg supplement
Description: L-Arg supplement will be prepared as pills, administered 9g each day in 3 times for 2 weeks.
Study NCT01350284 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Cinnamon
Description: acute oral administration of 3 g cinnamon
Study NCT03433963 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be prepared as pills (the same size, color and shape as of L-Arg), administered 3 times daily for 2 weeks.
Study NCT01350284 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Placebo control
Description: 3 g wheat flour (placebo)- separated by 28 days from cinnamon intervention
Study NCT02398305 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: TR Band standard
Description: Diminishing the air pressure in the TR Band following standard protocol
Study NCT02398305 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: TR Band Quick
Description: Diminishing the air pressure in the TR Band following a faster protocol
Study NCT01320059 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 18F-PEG6-IPQA
Description: Radioactive injection (PET imaging agent) given by vein before PET scans.
Study NCT01320059 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron emission tomography (PET)
Description: 3 PET scans performed after injection and positioning CT. Imaging should take about 3 hours.
Study NCT02497924 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GBT440
Description: GBT440 capsules followed by single dose of \[C14\] GBT440 oral suspension
Study NCT02158052 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tacrolimus
Description: Tacrolimus starting on Day -1
Study NCT02158052 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Equine Anti-thymocyte globulin
Description: 20 mg/kg IV on Days -3, -1, +1, +3
Study NCT02158052 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Kidney transplant from a related donor
Description: On Day 0 the renal transplant is performed according to standard surgical techniques.
Study NCT02158052 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Kidney transplant from a related donor
Description: On Day 0 the renal transplant is performed according to standard surgical techniques.
Study NCT02158052 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bone marrow transplant from a related donor
Description: Donor bone marrow (> 2 x 10e8 nucleated cells/kg of recipient body weight) is prepared for infusion according to the standard procedure. The infusion begins in the operating room as soon as the vascular anastomosis of the renal allograft has been completed.
Study NCT02158052 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Total body irradiation 400 centigray (200 cGy X 2)
Description: On transplant day -1
Study NCT00988078 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Capsule (without biologic action) administered three times a day for six months
Study NCT00988078 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin
Description: Metformin 500mg three times a day for six months
Study NCT00697931 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant MPL- adjuvanted hepatitis B vaccine
Description: Intramuscular injection, 3 doses
Study NCT00697931 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Engerix™-B
Description: Intramuscular injection, 3 doses
Study NCT03123601 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Risk sign displays
Description: Set of sign displays designed to communicate fall, dehydration and pulmonary aspiration risks and reflect on tailored interventions to manage these events in nursing homes. Risk sign displays are:~* Small, lightweight rubber coloured bracelets with phrases related with the different risks: prevent rather than fall, contain to protect, drink to hydrate and avoid choking.~* Small and coloured signposts next to head of patients bed that are believed to offer some key advantages and increase technically the quality of immediate communication of information and data regarding procedures. It is expected to have greater subject compliance once they will have discrete messages with thoughtful design and colour.
Study NCT04497064 — intervention group
Intervention type: OTHER
Intervention: survey
Description: survey asking questions regarding breakfast habits and composition, sports nutrition knowledge and exercise habits
Study NCT00543712 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PRO95780
Description: Intravenous repeating dose
Study NCT01015560 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: anti-CCR2 monoclonal antibody MLN1202
Study NCT01015560 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: polymorphism analysis
Study NCT01015560 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Study NCT04379063 — intervention group
Intervention type: OTHER
Intervention: COVID-19 pandemic
Description: Currently practicing during the COVID-19 pandemic
Study NCT02750774 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low-glycemic index group
Description: The dietary intervention consisted of the prescription of a Mediterranean style, low-glycaemic, low-fat, exchange diet (3 main meals and 3 snacks) with a total intake of 1500 kcal/day. In light of the PA, the dietitian adds 200 kcal/day for obese, 300 kcal/day for overweight women. The diet had a target macronutrient composition of 55% carbohydrates (80% complex carbohydrates with a low glycaemic index and 20% simple carbohydrates), 20% protein (50% animal and 50% vegetable) and 25% fat (12% mono-unsaturated, 7% polyunsaturated and 6% saturated) with moderately low saturated fat levels. The daily intake of carbohydrates was at least 225 g/day. The exercise intervention was focused on developing a more active lifestyle. The PA prescription is consistent with recommendations by the ACOG and ACSM for pregnant women. The talk test (being able to maintain a conversation during activity) was suggested to monitor the exercise intensity.
Study NCT02750774 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard Care Group
Description: Women randomized to the Standard Care Group received general information about healthy lifestyle during pregnancy, according to the Guidelines
Study NCT02631551 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSP 301 NS
Description: FDC of olopatadine HCl and mometasone furoate: 2 sprays in each nostril twice daily for 14 days
Study NCT02631551 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Olopatadine HCl NS
Description: 2 sprays in each nostril twice daily for 14 days
Study NCT02631551 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mometasone furoate NS
Description: 2 sprays in each nostril twice daily for 14 days
Study NCT02631551 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: GSP 301 Placebo NS
Description: 2 sprays in each nostril twice daily for 14 days
Study NCT04538937 — intervention group
Intervention type: OTHER
Intervention: no intervention
Description: no intervention
Study NCT03445884 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 68Ga-NODAGA-E[c(RGDyK)]2
Description: 200 MBq 68Ga-NODAGA-E\[c(RGDyK)\]2 administered IV.
Study NCT03445884 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 68Ga-NODAGA-E[c(RGDyK)]2
Description: 200 MBq 68Ga-NODAGA-E\[c(RGDyK)\]2 administered IV.
Study NCT00000145 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Antioxidants
Description: 500 milligrams vitamin C; 400 IUs vitamin E; 15 milligrams beta-carotene
Study NCT02338635 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic Acid
Description: Inhibition of ER stress (Ursodeoxycholic Acid)
Study NCT00000145 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Zinc
Description: 80 milligrams zinc oxide; 2 milligrams of cupric oxide
Study NCT00000145 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Antioxidants and zinc
Description: 500 milligrams vitamin C; 400 IUs vitamin E; 15 milligrams beta-carotene; 80 milligrams zinc oxide; 2 milligrams of cupric oxide
Study NCT03149809 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: solifenacin
Description: Antimuscarinic bladder relaxant, antagonizes bladder muscarinic receptors
Study NCT03149809 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Pelvic floor muscle exercise-based behavioral therapy
Description: Multicomponent intervention including fluid management, constipation management and behavioral techniques incorporating pelvic floor muscle-exercise based urge suppression and self-monitoring to reduce overactive bladder symptoms
Study NCT00839904 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: exercise
Description: two supervised, 60-minute weekly exercise sessions + instructions to perform additional physical activities throughout the day
Study NCT06114316 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: individualized nursing interventions based on the Roy Adaptation Model /experimental
Description: The personal behaviors that could be related to recurrence (physiological, self-concept, role function, and mutual commitment) and the stimuli that caused recurrence (focal and affecting) were assessed, objectives were determined, and nursing interventions were carried out in line with these objectives. The interventions planned for diagnosing ineffective coping were selected according to the patients' needs among the support coping interventions under the title of the behavioral area in the Nursing Intervention Classification (NIC). A total of 10 individual interviews were made twice a week for about 45 to 60 minutes. The interviews were evaluated by determining the area specific Nursing outcome classification (NOC) (self respect, social support, mood management, role performance).
Study NCT01882205 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual chromoendoscopy
Study NCT01882205 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Chromoendoscopy
Description: Panchromocolonoscopy with methyleen blue 0.1%